Arizona State Retirement System Acquires 1,351 Shares of Oscar Health, Inc. (NYSE:OSCR)

Arizona State Retirement System lifted its stake in Oscar Health, Inc. (NYSE:OSCR) by 3.7% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 38,059 shares of the company’s stock after purchasing an additional 1,351 shares during the quarter. Arizona State Retirement System’s holdings in Oscar Health were worth $602,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Victory Capital Management Inc. boosted its holdings in Oscar Health by 37.7% in the fourth quarter. Victory Capital Management Inc. now owns 18,852 shares of the company’s stock worth $172,000 after acquiring an additional 5,159 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Oscar Health by 3.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,160,483 shares of the company’s stock worth $10,618,000 after purchasing an additional 35,128 shares during the last quarter. Teacher Retirement System of Texas bought a new position in Oscar Health in the 4th quarter worth about $406,000. Dimensional Fund Advisors LP grew its position in Oscar Health by 14.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,162,935 shares of the company’s stock valued at $28,942,000 after purchasing an additional 392,837 shares during the last quarter. Finally, Principal Financial Group Inc. increased its stake in Oscar Health by 530.1% during the 4th quarter. Principal Financial Group Inc. now owns 141,919 shares of the company’s stock valued at $1,299,000 after purchasing an additional 119,397 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Insider Transactions at Oscar Health

In related news, insider Mario Schlosser sold 3,198 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the transaction, the insider now directly owns 76,982 shares of the company’s stock, valued at approximately $1,384,906.18. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other Oscar Health news, CAO Victoria Baltrus sold 4,226 shares of Oscar Health stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the transaction, the chief accounting officer now owns 140,648 shares of the company’s stock, valued at $2,530,257.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Mario Schlosser sold 3,198 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the sale, the insider now directly owns 76,982 shares of the company’s stock, valued at $1,384,906.18. The disclosure for this sale can be found here. Insiders have sold 169,569 shares of company stock worth $3,007,069 in the last 90 days. 25.11% of the stock is currently owned by insiders.

Oscar Health Stock Up 2.9 %

OSCR stock opened at $21.61 on Monday. Oscar Health, Inc. has a fifty-two week low of $4.72 and a fifty-two week high of $23.44. The business’s 50-day moving average is $17.27 and its two-hundred day moving average is $17.34. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.91. The company has a market cap of $5.13 billion, a price-to-earnings ratio of -54.03, a P/E/G ratio of 40.95 and a beta of 1.61.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.04. The firm had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.13 billion. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The business’s quarterly revenue was up 44.6% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.07) EPS. As a group, analysts forecast that Oscar Health, Inc. will post 0.01 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on OSCR shares. Bank of America reiterated a “neutral” rating and issued a $21.00 target price (down previously from $25.00) on shares of Oscar Health in a research note on Thursday, May 30th. Baird R W upgraded Oscar Health to a “strong-buy” rating in a research note on Thursday, May 30th. Robert W. Baird initiated coverage on Oscar Health in a research note on Thursday, May 30th. They issued an “outperform” rating and a $28.00 price target for the company. Wells Fargo & Company upped their price target on Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a report on Wednesday, June 12th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a report on Tuesday, September 10th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Oscar Health has an average rating of “Moderate Buy” and an average price target of $24.17.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.